Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 43 | 46 | 40 | 43 | 40 | 38 | 35 | 46 | 54 | 57 | 49 | 59 |
| Expenses | 35 | 35 | 33 | 35 | 32 | 33 | 31 | 38 | 45 | 46 | 39 | 47 |
| Operating Profit | 9 | 11 | 7 | 8 | 8 | 5 | 5 | 9 | 9 | 11 | 10 | 12 |
| OPM % | 20% | 23% | 18% | 19% | 19% | 13% | 13% | 19% | 17% | 19% | 20% | 21% |
| Other Income | 1 | 0 | 0 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 8 | 10 | 6 | 8 | 7 | 5 | 5 | 8 | 9 | 11 | 10 | 13 |
| Tax % | 26% | 26% | 24% | 24% | 25% | 26% | 25% | 24% | 26% | 26% | 36% | 26% |
| Net Profit | 7 | 7 | 5 | 6 | 7 | 4 | 4 | 7 | 8 | 9 | 7 | 11 |
| EPS in Rs | 1.58 | 1.74 | 1.21 | 1.55 | 1.62 | 1.06 | 0.98 | 1.66 | 1.88 | 2.07 | 1.63 | 2.63 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 46 | 53 | 57 | 65 | 79 | 142 | 124 | 144 | 164 | 156 | 206 | 219 |
| Expenses | 42 | 47 | 50 | 56 | 66 | 96 | 92 | 114 | 130 | 131 | 168 | 176 |
| Operating Profit | 4 | 5 | 7 | 9 | 13 | 46 | 31 | 30 | 34 | 25 | 39 | 42 |
| OPM % | 9% | 10% | 12% | 14% | 17% | 32% | 25% | 21% | 21% | 16% | 19% | 19% |
| Other Income | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 | 4 | 5 | 6 |
| Interest | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 5 | 5 |
| Profit before tax | 3 | 3 | 4 | 6 | 10 | 43 | 29 | 28 | 32 | 24 | 38 | 43 |
| Tax % | 34% | 35% | 35% | 30% | 25% | 26% | 25% | 25% | 25% | 25% | 28% | |
| Net Profit | 2 | 2 | 3 | 4 | 8 | 32 | 22 | 25 | 25 | 22 | 30 | 34 |
| EPS in Rs | 0.46 | 0.56 | 0.66 | 0.85 | 1.71 | 7.35 | 5.25 | 6.01 | 6.02 | 5.21 | 7.23 | 8.21 |
| Dividend Payout % | 33% | 27% | 23% | 0% | 12% | 4% | 6% | 6% | 7% | 8% | 7% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 16% | 8% | 13% | 37% | ||
| Compounded Profit Growth | 33% | 0% | 6% | 54% | ||
| Stock Price CAGR | 48% | 43% | 77% | 108% | ||
| Return on Equity | 22% | 20% | 18% | 18% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 13 | 14 | 15 | 17 | 24 | 31 | 60 | 78 | 102 | 125 | 145 | 173 |
| Borrowings | 8 | 11 | 22 | 26 | 24 | 24 | 16 | 9 | 9 | 8 | 3 | 6 |
| Other Liabilities | 5 | 7 | 7 | 7 | 9 | 13 | 16 | 13 | 16 | 15 | 19 | 27 |
| Total Liabilities | 34 | 40 | 52 | 57 | 65 | 76 | 101 | 108 | 135 | 157 | 175 | 214 |
| Fixed Assets | 11 | 11 | 13 | 14 | 29 | 31 | 34 | 35 | 36 | 52 | 57 | 62 |
| CWIP | 1 | 5 | 9 | 13 | 0 | 0 | 0 | 4 | 13 | 3 | 2 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 15 | 28 | 33 | 60 |
| Other Assets | 21 | 24 | 30 | 30 | 36 | 45 | 67 | 65 | 70 | 74 | 83 | 90 |
| Total Assets | 34 | 40 | 52 | 57 | 65 | 76 | 101 | 108 | 135 | 157 | 175 | 214 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -2 | 5 | 0 | 2 | 5 | 6 | 19 | 22 | 21 | 21 | 20 | 30 |
| Cash from Investing Activity | -3 | -5 | -8 | -6 | -4 | -2 | -5 | -16 | -21 | -20 | -10 | -34 |
| Cash from Financing Activity | 3 | 2 | 9 | 0 | -0 | -4 | -11 | -4 | -2 | -3 | -8 | 0 |
| Net Cash Flow | -2 | 2 | 1 | -3 | 1 | -0 | 4 | 2 | -2 | -2 | 2 | -4 |
| Free Cash Flow | -3 | 0 | -7 | -4 | 1 | 8 | 14 | 8 | 8 | 12 | 12 | 21 |
| CFO/OP | -28% | 143% | 21% | 43% | 74% | 62% | 65% | 93% | 97% | 85% | 103% | 101% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 47 | 44 | 49 | 52 | 54 | 46 | 48 | 53 | 42 | 44 | 40 |
| Inventory Days | 134 | 118 | 155 | 202 | 236 | 259 | 177 | 206 | 179 | 208 | 242 | 212 |
| Days Payable | 17 | 18 | 15 | 13 | 24 | 38 | 20 | 25 | 27 | 15 | 25 | 32 |
| Cash Conversion Cycle | 175 | 147 | 184 | 239 | 264 | 276 | 203 | 230 | 205 | 234 | 261 | 220 |
| Working Capital Days | 94 | 60 | 90 | 108 | 97 | 101 | 88 | 118 | 109 | 111 | 130 | 102 |
| ROCE % | 12% | 12% | 13% | 15% | 20% | 58% | 32% | 27% | 25% | 17% | 23% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 55.87% | 55.87% | 55.87% | 55.87% | 55.87% | 55.87% | 55.87% | 55.87% | 55.78% | 55.78% | 55.78% | 55.78% |
| DIIs | 0.00% | 0.00% | 0.23% | 0.00% | 0.00% | 0.00% | 0.01% | 0.03% | 0.03% | 0.03% | 0.03% | 0.01% |
| Public | 44.13% | 44.12% | 43.90% | 44.12% | 44.13% | 44.12% | 44.11% | 44.10% | 44.19% | 44.19% | 44.19% | 44.21% |
| No. of Shareholders | 17,455 | 15,756 | 15,876 | 15,850 | 15,700 | 16,038 | 16,370 | 16,328 | 16,040 | 16,367 | 17,457 | 18,671 |
Fundamentals
Market Cap₹ 1,615 Cr.
Current Price₹ 391
Stock P/E47.7
Book Value₹ 43.9
ROCE22.8 %
ROE17.8 %
Dividend Yield0.13 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)37%
Compounded Profit Growth (TTM)54%
Consolidated figures.
Valuation
Market capRs 1,618 Cr
Enterprise valueRs 1,621 Cr
P/E (TTM)47.75x
Price to book8.91x
Price to sales7.39x
EV / EBITDA33.19x
EV / EBIT37.10x
EV / sales7.41x
Price to cash flow53.18x
Earnings yield2.09%
Dividend yield0.13%
P/E, 3-year average3.37x
P/B, 3-year average0.55x
P/E, 5-year average2.51x
P/B, 5-year average0.48x
Profitability
Operating margin (excl. other income)18.72%
Operating margin (incl. other income)21.34%
EBITDA margin22.32%
Pre-tax margin19.55%
Net profit margin15.48%
Net margin, latest quarter18.35%
ROE17.85%
ROCE22.76%
ROA15.38%
ROE, 3-year average17.76%
ROCE, 3-year average21.60%
ROA, 3-year average15.14%
ROE, 5-year average21.32%
ROCE, 5-year average25.00%
ROA, 5-year average17.33%
ROIC (approx.)16.95%
Tax rate28.11%
Other income / net worth2.98%
Growth
Sales growth (latest year)31.79%
Profit growth (latest year)38.83%
Sales CAGR, 3 years12.71%
Sales CAGR, 5 years7.71%
Profit CAGR, 3 years6.36%
Profit CAGR, 5 years-0.30%
Sales growth QoQ21.18%
Profit growth QoQ61.37%
Sales growth YoY (latest quarter)27.25%
Profit growth YoY (latest quarter)58.31%
Per share
EPS (TTM)Rs 8.20
EPS (latest quarter)Rs 2.63
EPS, 3-year averageRs 28.06
EPS, 5-year averageRs 28.10
Book value per shareRs 43.94
Sales per shareRs 52.97
Cash flow per shareRs 7.36
Free cash flow per shareRs 5.08
Dividend per share, 3-year averageRs 2.00
Dividend per share, 5-year averageRs 1.82
Dividends
Dividend payout6.89%
Dividend payout, 3-year average7.07%
Dividend payout, 5-year average6.58%
Efficiency
Asset turnover0.96x
Fixed asset turnover3.35x
Inventory turnover1.72x
Inventory days212 days
Debtor days40 days
Debtors turnover9.03x
Creditor days32 days
Cash conversion cycle220 days
Working capital days102 days
Leverage
Total debtRs 6 Cr
Cash and bankRs 2 Cr
Net debtRs 4 Cr
Debt to equity0.03x
Net debt / EBITDA0.08x
Interest coverage47.51x
Owners' fund to total sources84.88%
Debt to assets2.67%
Cash flow
Cash from Operating Activity (latest year)Rs 30 Cr
Cash from Investing Activity (latest year)Rs -34 Cr
Cash from Financing Activity (latest year)Rs 0 Cr
Net Cash Flow (latest year)Rs -4 Cr
Free cash flow (latest year)Rs 21 Cr
FCFE (approx.: FCF + change in debt)Rs 24 Cr
Cash from ops / profit, 5 years0.92x
Sales to cash flow6.78x
Statement figures
Net sales (TTM)Rs 219 Cr
Net sales (latest year)Rs 206 Cr
Sales (latest quarter)Rs 59 Cr
Operating profit excl. other income (latest year)Rs 39 Cr
Operating profit (latest quarter)Rs 12 Cr
Other income (TTM)Rs 6 Cr
EBITDA (TTM)Rs 49 Cr
PBDT (TTM)Rs 48 Cr
Profit before tax (TTM)Rs 43 Cr
Tax (latest year)Rs 11 Cr
Net profit (TTM)Rs 34 Cr
Net profit (latest year)Rs 30 Cr
Net profit (latest quarter)Rs 11 Cr
Depreciation (TTM)Rs 5 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 96 Cr
Total expenditure (latest year)Rs 168 Cr
Total income (latest year)Rs 212 Cr
Share capitalRs 8 Cr
ReservesRs 173 Cr
Shareholders' fundsRs 182 Cr
Total assetsRs 214 Cr
Net blockRs 62 Cr
Capital work in progressRs 2 Cr
InvestmentsRs 60 Cr
ReceivablesRs 23 Cr
InventoryRs 56 Cr
Other liabilitiesRs 27 Cr
Shares outstanding (crore)4.13
Ownership
Promoter holding55.78% (-0.09 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 47.8 is at the 94th percentile of its own 9.4-year range
(median 15.6, low 6.3, high 75.3).
P/B 8.91 is at the 95th percentile (median 2.69).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 524717 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -1.4% | -2.8% | +1.4 pts |
| 1 month | +3.1% | -6.8% | +9.8 pts |
| 3 months | +0.3% | -7.6% | +7.9 pts |
| 3 years | +457.0% | +14.2% | +442.8 pts |
| 5 years | +482.3% | +27.9% | +454.4 pts |
Red flags
F-score 7 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹59 Cr +28.3% vs Jun 2025.
Net profit ₹11 Cr +57.1%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Pidilite Industries Ltd | 148,809 | 56.2 | 31.0 % |
| Gujarat Fluorochemicals Ltd | 48,402 | 78.4 | 9.64 % |
| Navin Fluorine International Ltd | 42,255 | 53.1 | 21.0 % |
| Aether Industries Ltd | 23,226 | 96.8 | 11.9 % |
| Deepak Nitrite Ltd | 20,854 | 26.3 | 11.4 % |
| Atul Ltd | 17,614 | 22.1 | 14.9 % |
| Aarti Industries Ltd | 17,045 | 32.6 | 6.86 % |
| Fine Organic Industries Ltd | 15,759 | 36.0 | 21.5 % |
| BASF India Ltd | 14,871 | 24.0 | 14.5 % |
| Privi Speciality Chemicals Ltd | 14,084 | 40.3 | 22.3 % |
| Anupam Rasayan India Ltd | 13,409 | 76.8 | 7.38 % |
| Vinati Organics Ltd | 12,173 | 24.4 | 21.4 % |
| Elantas Beck India Ltd | 10,820 | 60.9 | 21.2 % |
| Jubilant Ingrevia Ltd | 10,180 | 32.0 | 11.4 % |
| Alkyl Amines Chemicals Ltd | 9,111 | 40.5 | 16.6 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Titan Biotech Ltd?
Titan Biotech Ltd (524717) has a market capitalisation of Rs 1,615 Cr. at the 2026-10-01 close.
What is the P/E ratio of Titan Biotech Ltd?
Titan Biotech Ltd trades at a P/E of 47.7 on trailing twelve-month profit, at the 2026-10-01 close.
What were Titan Biotech Ltd's latest quarterly results?
In the Jun 2026 quarter, Titan Biotech Ltd sales was Rs 59 Cr (+28.3% vs Jun 2025) and net profit was Rs 11 Cr.